Hvsen Biotechnology Co., Ltd.
SZSE:300871.SZ
14.16 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 293.61 | 424.044 | 1,068.234 | 345.343 | 104.456 | 99.455 | 53.444 | 52.278 |
| Short Term Investments
| 304.257 | 361.677 | 30.216 | 240.633 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 597.867 | 785.722 | 1,098.45 | 585.977 | 104.456 | 99.455 | 53.444 | 52.278 |
| Net Receivables
| 376.64 | 354.411 | 249.397 | 235.4 | 106.531 | 88.968 | 43.434 | 27.842 |
| Inventory
| 228.67 | 199.006 | 231.551 | 127.268 | 72.416 | 82.28 | 57.903 | 47.962 |
| Other Current Assets
| 62.804 | 12.336 | 19.484 | 228.507 | 9.139 | 5.049 | 43.35 | 8.5 |
| Total Current Assets
| 1,265.981 | 1,351.475 | 1,598.882 | 1,177.152 | 292.543 | 275.751 | 177.7 | 136.583 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 1,566.159 | 1,498.079 | 1,006.798 | 412.329 | 233.306 | 114.365 | 98.451 | 88.346 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 104.172 | 106.874 | 110.059 | 95.771 | 98.189 | 63.583 | 65.071 | 28.282 |
| Goodwill and Intangible Assets
| 104.172 | 106.874 | 110.059 | 95.771 | 98.189 | 63.583 | 65.071 | 28.282 |
| Long Term Investments
| 0 | 12.234 | 0 | 2.007 | 1.377 | 0.318 | 1.255 | 0.494 |
| Tax Assets
| 21.653 | 12.91 | 10.46 | 8.251 | 9.149 | 3.021 | 0.954 | 1.153 |
| Other Non-Current Assets
| 17.496 | 7.543 | 15.463 | 56.715 | 15.518 | 9.558 | 0.743 | 1.002 |
| Total Non-Current Assets
| 1,709.48 | 1,637.639 | 1,142.78 | 575.074 | 357.538 | 190.844 | 166.476 | 119.276 |
| Total Assets
| 2,975.46 | 2,989.114 | 2,741.662 | 1,752.226 | 650.081 | 466.596 | 344.175 | 255.859 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 472.469 | 489.703 | 249.115 | 194.437 | 121.05 | 70.446 | 44.102 | 9.612 |
| Short Term Debt
| 240.587 | 220.085 | 112.833 | 63 | 29 | 25 | 0 | 0 |
| Tax Payables
| 8.135 | 12.922 | 4.866 | 9.089 | 11.491 | 7.233 | 9.598 | 4.686 |
| Deferred Revenue
| 0 | 85.217 | 76.083 | 55.205 | 33.818 | 36.635 | 16.688 | 10.056 |
| Other Current Liabilities
| 59.886 | 66.598 | 122.586 | 16.94 | 8.408 | -0.39 | 64.381 | 73.56 |
| Total Current Liabilities
| 781.076 | 804.925 | 503.269 | 338.672 | 203.767 | 138.924 | 118.081 | 98.003 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 601.657 | 570.36 | 574.565 | 0 | 33.7 | 1 | 1 | 1 |
| Deferred Revenue Non-Current
| 62.339 | 48.889 | 42.08 | 24.703 | 23.547 | 1.407 | 1.231 | 1.406 |
| Deferred Tax Liabilities Non-Current
| 20.262 | 21.818 | 0 | -6.417 | 10.035 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.845 | 1.69 | 44.975 | 9.702 | 24.297 | 2.157 | 1.981 | 0.75 |
| Total Non-Current Liabilities
| 685.103 | 642.757 | 619.539 | 34.404 | 68.032 | 3.157 | 2.981 | 3.156 |
| Total Liabilities
| 1,466.179 | 1,447.682 | 1,122.808 | 373.076 | 271.799 | 142.081 | 121.062 | 101.159 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 165.887 | 166.055 | 166.249 | 110.507 | 82.807 | 82.807 | 80 | 80 |
| Retained Earnings
| 341.942 | 376.221 | 381.853 | 311.616 | 172.71 | 123.504 | 77.249 | 15.825 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 122.074 | 190.091 | 957.027 | 141.655 | 118.208 | 65.868 | 58.871 |
| Other Total Stockholders Equity
| 1,001.451 | 999.157 | 1,070.752 | 957.027 | 122.765 | 103.874 | 65.864 | -0.007 |
| Total Shareholders Equity
| 1,509.281 | 1,541.432 | 1,618.854 | 1,379.15 | 378.281 | 324.515 | 223.114 | 154.689 |
| Total Equity
| 1,509.281 | 1,541.432 | 1,618.854 | 1,379.15 | 378.281 | 324.515 | 223.114 | 154.701 |
| Total Liabilities & Shareholders Equity
| 2,975.46 | 2,989.114 | 2,741.662 | 1,752.226 | 650.081 | 466.596 | 344.175 | 255.859 |